Soshi Iwasaki

Dr. Soshi Iwasaki


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2021 in Research Square
Verified
Preprint
Open access
PDF file
SISoshi Iwasaki
Soshi Iwasaki
YKYoshiyasu Kigawa
Yoshiyasu Kigawa
KTKazunobu Takahashi
Kazunobu Takahashi
MYMichiaki Yamakage
Michiaki Yamakage
Although the primary mechanism for the spread of coronavirus disease 2019 (COVID-19) infection is through respiratory droplets (1), the virus that causes COVID-19 can survive on smooth surfaces (e.g., stainless steel, plastic, glass) for days at low temperatures (2). Surface transmission represents a possible route of infection, as unwashed hands that touch a contaminated surface can transfer the virus to mucous membranes (e.g., eyes, nose, mouth) (3). However, it is difficult to observe disease transmission directly. Therefore, the Japanese Cluster Countermeasures team has identified the “Three Cs”—Closed spaces with poor ventilation, Crowded places, and Close-contact settings—as factors to avoid to prevent COVID-19 clusters. Identifying other environmental factors that increase or decrease the number of infections would be useful to prevent the spread of COVID-19. Therefore, this study aimed to develop a shoe-related transmission model and enhance COVID-19 transmission route precautions by investigating the associations between the prevalence of COVID-19 and both population density and the distribution of tatami stores in each prefecture in Japan. As a result, a significant negative relationship was observed between the number of tatami stores per 100,000 population and the number of COVID-19 cases and deaths.

12 June 2017 in JA Clinical Reports
Verified
Journal Article
Open access
PDF file
KYKaoru Yoshioka
Kaoru Yoshioka
KOKatsuya Ohmori
Katsuya Ohmori
SISoshi Iwasaki
Soshi Iwasaki
KTKazunobu Takahashi
Kazunobu Takahashi
ASAkemi Sato
Akemi Sato
MYMichiaki Yamakage
Michiaki Yamakage
Warfarin, a widely used anticoagulant, interacts with various agents used in palliative care, such as oxycodone, morphine, acetaminophen, and non-steroidal anti-inflammatory drugs (NSAIDs); however, there are no reports of its interaction with methadone. We report a case of a patient receiving warfarin when methadone was introduced for pain control with monitoring of the prothrombin time-international normalized ratio (PT-INR) and deduced the pharmacological background. A 60-year-old male was emergently admitted to our university hospital for the sudden onset of severe back pain. Abdominal CT imaging revealed that the vertebral body of the ninth thoracic vertebra was occupied by bone metastasis and crushed, which caused his back pain. He received warfarin 3.5 mg/day for atrial fibrillation and tapentadol 100 mg p.o. daily for pain relief. The prothrombin time-international normalized ratio (PT-INR) was maintained at >2.2. The patient’s history included diabetes mellitus and hypertension, but his laboratory test was unremarkable with the exception that his eGFR was 34 ml/min. Initially, a fentanyl dermal patch was used instead of tapentadol to avoid interactions with warfarin. We started concomitant administration of oxycodone and 2.4 g/day of acetaminophen while monitoring the PT-INR because acetaminophen increased the PT-INR to 2.93. A continuous intravenous infusion of oxycodone was introduced, in increments of the dose, resulting in an increase of the PT-INR to 3.41, which is required to reduce the dose of warfarin to 1.5 mg. Because of the lack of effective pain relief, methadone was introduced and the dose was gradually increased. The PT-INR was not changed and the dose of warfarin was not changed. An infusion of oxycodone and oral methadone was used to allow the patient to walk in his room, and he was later transferred to the palliative hospital. In an oral warfarinized patient, methadone seemed to undergo different metabolism than oxycodone. When warfarin and methadone are used together, we have to consider their interaction by comparing the competitive inhibition of CYP2C9 to the induction of CYP3A4 by methadone, because CYP3A4 metabolize various drugs including oxycodone.

2 December 2020 in Research Square
Verified
Preprint
Open access
PDF file
SISoshi Iwasaki
Soshi Iwasaki
KTKazunobu Takahashi
Kazunobu Takahashi
MYMichiaki Yamakage
Michiaki Yamakage
Japan has had a lower number of SARS-CoV-2 cases than anticipated. Hence, we hypothesize that the habit of removing shoes indoors, which is practiced in various countries, might influence the SARS-CoV-2 transmission patterns and COVID-19 associated morbidity and mortality through transmission-based infection. There are significantly fewer COVID-19 deaths in countries that follow the cultural practice of removing shoes indoors.

1 January 2015
Verified
Journal Article
Closed access
MHMaiko Homma
Maiko Homma
SISoshi Iwasaki
Soshi Iwasaki
FSFumiyuki Sugime
Fumiyuki Sugime
TMTakeshi Murouchi
Takeshi Murouchi
MYMichiaki Yamakage
Michiaki Yamakage

1 September 2012
Verified
Journal Article
Closed access
MYMitsunori Yoshimoto
Mitsunori Yoshimoto
TYToshihiko Yamashita
Toshihiko Yamashita
SISoshi Iwasaki
Soshi Iwasaki
MYMichiaki Yamakage
Michiaki Yamakage

20 July 2014 in Case Reports in Anesthesiology
Verified
Journal Article
Open access
PDF file
KSKartika Balaji Samala
Kartika Balaji Samala
YUYuri Uchiyama
Yuri Uchiyama
YTYasuyuki Tokinaga
Yasuyuki Tokinaga
YNYukitoshi Niiyama
Yukitoshi Niiyama
SISoshi Iwasaki
Soshi Iwasaki
MYMichiaki Yamakage
Michiaki Yamakage
31-year-old female with hypersensitivity to local anesthetics and neuromuscular blocking agents presented for emergency Cesarean section. We successfully performed I-gel-assisted tracheal intubation without using neuromuscular blockers. We believe this method would be helpful in selected situations.